跳至主要内容
临床试验/TCTR20220629008
TCTR20220629008尚未招募1 期

Effects of acupuncture on anxiety, depression and quality of life of patients with coronary artery disease after percutaneous coronary intervention: study protocol for a randomized, blinded, placebo-controlled trial

Xiaoxia Wang0 个研究点目标入组 74 人开始时间: 2022年6月29日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • 1. CAD patients with anxiety and depression after PCI; Hamilton Anxiety Rating Scale (HAMA) score at least7 points, and Hamilton Depression Rating Scale (HAMD) score at least14 points;
  • 2.Aged 18 to 85;
  • 3.No anti-anxiety or depression medication within the last 2 weeks;
  • 4.Voluntarily accepted the random grouping and signed the informed consent form.

排除标准

  • 1.Patients with combined severe or unstable cardiac, cerebral, hepatic, renal, endocrine, hematological and other medical diseases;
  • 2.Patients with progressive development or very poor prognosis, such as severe infections, severe water-electrolyte disorders, acid-base imbalance;
  • 3. Patients with severe anxiety and depression, requiring oral anti-anxiety and depression drugs;
  • 4. Patients with severe cognitive dysfunction who are unable to communicate;
  • 5.Pregnant and lactating women.

研究者

发起方
Xiaoxia Wang

相似试验